Persephone Biosciences uses artificial intelligence to rapidly develop microbial based immunotherapies to enable a lifetime without cancer.
Persephone Biosciences has raised $15.0M in total funding. The most recent round was Seed. The last funding was announced in July 2022.
Persephone Biosciences's investors include Y Combinator, Pioneer Fund, Susa Ventures, ZhenFund, Fifty Years.
Persephone Biosciences is headquartered in San Diego, United States.
Persephone Biosciences uses artificial intelligence to rapidly develop microbial based immunotherapies to enable a lifetime without cancer.
Persephone Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Persephone Biosciences — Funding & Investors." VCBacked, July 19, 2022, https://www.vcbacked.co/company/persephone-biosciences. Accessed August 13, 2026.
VCBacked. (2022). Persephone Biosciences — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/persephone-biosciences
{{cite web |title=Persephone Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/persephone-biosciences |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated